SLIT2 Promoter Hypermethylation Predicts Disease Progression in Chronic Myeloid Leukemia

0
243
The level of SLIT2 promoter methylation was determined in 104 chronic myeloid leukemia patients, and its clinical significance was analyzed.
[European Journal of Medical Research]
Full Article